The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/22893
StudyName: Eligibility Recurrent Adult Acute Lymphoblastic Leukemia NCT00262925
Date of export from the portal: 02.07.2020
Date of Upload / last change: 14.06.2017
License: Creative Commons BY 4.0

----

Description: 
Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00262925
